Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Drivers
4.1.1 Growing R&D Activities in the Field of Biological and Chemical Sciences
4.1.2 Increasing Usage in Wastewater Treatment
4.2 Restraints
4.2.1 Availability of Substitutes for Laboratory Chemicals
4.2.2 Other Restraints
4.3 Industry Value-Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition


5 MARKET SEGMENTATION
5.1 Type
5.1.1 Molecular Biology
5.1.2 Cytokine and Chemokine Testing
5.1.3 Carbohydrate Analysis
5.1.4 Immunochemistry
5.1.5 Cell/Tissue Culture
5.1.6 Environmental Testing
5.1.7 Biochemistry
5.1.8 Other Types
5.2 Application
5.2.1 Industrial
5.2.2 Education
5.2.3 Government
5.2.4 Healthcare
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 Italy
5.3.3.4 France
5.3.3.5 Spain
5.3.3.6 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle East & Africa


6 COMPETITIVE LANDSCAPE
6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Avantor Inc.
6.4.2 BD BioScience
6.4.3 Beckman Coulter Inc.
6.4.4 BiosYnth SRL
6.4.5 Carlo Erba Reagents SRL
6.4.6 GE Healthcare
6.4.7 ITW Reagents Division
6.4.8 Merck KGaA
6.4.9 Meridian Life Science Inc.
6.4.10 Mitsubishi Rayon Co. Ltd
6.4.11 Morphisto GmbH
6.4.12 Nova Chimica SRL
6.4.13 PerkinElmer Inc.
6.4.14 R&D Systems
6.4.15 Sigma-Aldrich Corp.
6.4.16 UJIFILM Wako Chemicals


7 MARKET OPPORTUNITIES AND FUTURE TRENDS
7.1 Advancement in Technologies, such as Cell Culture, Recombinant DNA, and Biotherapeutics
7.2 Other Opportunities